The obstetric and gynaecological management of women with inherited bleeding disorders – review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors’ Organization
Tóm tắt
Từ khóa
Tài liệu tham khảo
Gill JC, 1999, The role of genetics in inhibitor formation, Thromb Haemost, 82, 500, 10.1055/s-0037-1615871
McIntyre L, 2001, Pre‐implantation diagnosis, STEER: Succinct Timely Eval Evid Rev, 1, 1
Human Fertilisation and Embryology Authority, 2006, HFEA Guide to Infertility and Directory of Clinics 2005/06
Department of Health UK, 2002, Preimplantation Genetic Diagnosis (PGD) – Guiding Principles for Commissioners of NHS Services
Forestier F, 1985, Vitamin K dependent proteins in fetal hemostasis at mid trimester of pregnancy, Thromb Haemost, 53, 401, 10.1055/s-0038-1661323
Royal College of Obstetricians and Gynaecologists, 2005, Amniocentesis and Chorionic Villus Sampling
Plattner G, 1983, Fetal sex determination by ultrasound scan in the second and third trimesters, Obstet Gynecol, 61, 454
Mannucci PM, 1997, Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years, Blood, 90, 2515, 10.1182/blood.V90.7.2515
Hoveyda F, 2001, BJOG, 927
Van Der Bom JG, 2003, Age at first treatment and immune tolerance to factor VIII in severe hemophilia, Thromb Haemost, 89, 475, 10.1055/s-0037-1613376
Miller CH, 1982, Hemophilia in the Child and Adult, 29
Hanna W, 1981, Variant von Willebrand's disease and pregnancy, Blood, 58, 873, 10.1182/blood.V58.5.873.873
Conti M, 1986, Pregnancy in women with different types of von Willebrand disease, Obstet Gynecol, 68, 282
Rick ME, 1987, Thrombocytopenia associated with pregnancy in a patient with type IIB von Willebrand's disease, Blood, 69, 786, 10.1182/blood.V69.3.786.786
Lindoff C, 1993, Treatment with tranexamic acid during pregnancy, and the risk of thrombo‐embolic complications, Thromb Haemost, 70, 238, 10.1055/s-0038-1649475
Cohen S, 1989, Epidural analgesia for labor and delivery in a patient with von Willebrand's disease, Reg Anesth, 14, 95
Kulkarni A, 2005, Assessment of Factor VIII and von Willebrand Factor Levels in Cord Blood
Rapaport SI, 1961, The mode of inheritance of PTA deficiency: evidence for the existence of major PTA deficiency and minor PTA deficiency, Blood, 18, 149, 10.1182/blood.V18.2.149.149
Nossel HL, 1966, A study of coagulation factor levels in women during labour and in their newborn infants, Thromb Diath Haemorrh, 16, 185
Royal College of Obstetricians and Gynaecologists, 1998, The Initial Management of Menorrhagia – National Evidence‐based Clinical Guidelines
Royal College of Obstetricians and Gynaecologists, 1999, The Management of Menorrhagia in Secondary Care – National Evidence‐based Clinical Guidelines
Falcone T, 1994, Dysfunctional uterine bleeding in adolescents, J Reprod Med, 39, 761
Federici AB, 2003, The factor VIII/von Willebrand factor complex: basic and clinical issues, Haematologica, 88, EREP02
Kouides P, 1997, Adjusting the reference range of von Willebrand factor levels and factor VIII:C levels in relation to the menstrual cycle, Blood, 90, 32a
Mangal AK, 1983, Oral contraceptives and von Willebrand's disease, Can Med Assoc J, 128, 1274
Khan A, 2004, A first year clinical review of the multidisciplinary haemophilia/obstetrics and gynaecology clinic at the Royal Free Hospital Haemophilia Centre, Haemophilia, 10, 143
Lethaby A, 2000, Antifibrinolytics for heavy menstrual bleeding, Cochrane Database Syst Rev, CD000249
Rybo G, 1991, Tranexamic acid therapy: effective treatment in heavy menstrual bleeding: clinical update on safety, Therapeutic Adv, 4, 1
British Medical Association and the Royal Pharmaceutical Society of Great Britain, 2004, British National Formulary
Ramcharan S, 1980, The Walnut Creek Contraceptive Drug Study. A prospective study of the side effects of oral contraceptives. Volume III, an interim report: a comparison of disease occurrence leading to hospitalization or death in users and nonusers of oral contraceptives, J Reprod Med, 25, 345
Edelman AB, 2005, Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception, Cochrane Database Syst Rev, CD004695
Cash JD, 1974, Proceedings: the release of plasminogen activator and factor VIII to lysine vasopressin, arginine vasopressin, I‐desamino‐8‐d‐arginine vasopressin, angiotensin and oxytocin in man, Br J Haematol, 27, 363
Bonnar J, 1983, The haemostatic system and dysfunctional uterine bleeding, Res Clin Forum, 5, 27
Rodeghiero F, 1996, Prospective multicenter study on subcutaneous concentrated desmopressin for home treatment of patients with von Willebrand disease and mild or moderate hemophilia A, Thromb Haemost, 76, 692, 10.1055/s-0038-1650645
Lethaby A, 2000, Cyclical progestogens for heavy menstrual bleeding, Cochrane Database Syst Rev, CD001016
Lethaby A, 2000, Nonsteroidal anti‐inflammatory drugs for heavy menstrual bleeding, Cochrane Database Syst Rev, CD000400
Lethaby AE, 2000, Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding, Cochrane Database Syst Rev, CD002126
Lethaby A, 2000, Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding, Cochrane Database Syst Rev, CD000329
Silwer J, 1973, von Willebrand's disease in Sweden, Acta Paediatr Scand Suppl, 238, 1
Hann LE, 1979, Mittelschmerz. Sonographic demonstration, JAMA, 241, 2731, 10.1001/jama.1979.03290510039024
Bottini E, 1991, Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III von Willebrand disease and afibrinogenemia. Case reports, Haematologica, 76, 431